The goal of most microarray experiments is to survey patterns of gene expression by assaying the expression levels of thousands to tens of thousands of genes in a single assay. Typically, RNA is first ...

Although there is only one human genome sequence, different genes are expressed in many different cell types and tissues, as well as in different developmental stages or diseases. The structure of ...

The SureScan Microarray Scanner is a key component of Agilent’s complete microarray solution. With improved feature resolution, it delivers exceptional flexibility to analyze any microarray ...

One seismometer is often not enough to reliably detect earthquakes or human activity such as underground nuclear tests.

Unity, a microreactor from Houston-based Deployable Energy, is the latest of the three to reach criticality as part of a ...

The largest digital camera ever built is starting to capture images of unseen corners of the universe. The Vera C. Rubin ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

A radio telescope project known as the Deep Synoptic Array is moving forward. It aims to detect radio waves emitted by stars, planets, galaxies and other celestial objects.

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.